Anthony Cordone
@Armistice Capital, Llc
Latest period2024 - Q3ReportedManaged Assets$6.253BTotal holdings256
Assets growth rate-21.32%Assets growth rate (2-Q avg)-7.96%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Armistice Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 256 positions.
Assets under management
The assets under management (AUM) of Armistice Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.253B in assets, with a quarterly growth rate of -21.32% and a 2-quarter average growth rate of -7.96%. The portfolio is managed by Anthony Cordone, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
VNRXVolitionrx Ltd
| 0.09% | $5.408M 8.999M shares@ $0.61 avg price | New Position |
ETSYEtsy Inc
| 0.09% | $5.007M 90,164 shares@ $55.54 avg price | New Position |
ALURAllurion Technologies Inc
| 0.08% | $4.785M 7.806M shares@ $0.62 avg price | New Position |
RVPHReviva Pharmaceutcls Hldgs I
| 0.08% | $4.588M 3.186M shares@ $1.44 avg price | New Position |
VSTMVerastem Inc
| 0.07% | $4.078M 1.364M shares@ $2.99 avg price | New Position |
RSIRush Street Interactive Inc
| 0.07% | $3.797M 350,000 shares@ $10.85 avg price | New Position |
ONDSOndas Hldgs Inc
| 0.06% | $3.662M 4.75M shares@ $0.78 avg price | New Position |
FDMT4d Molecular Therapeutics In
| 0.06% | $3.632M 336,000 shares@ $10.81 avg price | New Position |
NPCENeuropace Inc
| 0.06% | $3.346M 480,000 shares@ $6.97 avg price | New Position |
PMNPromis Neurosciences Inc
| 0.06% | $3.337M 2.67M shares@ $1.25 avg price | New Position |